Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-acting growth hormone administration study in healthy adults
jRCT1001220001Completed
- Sponsor
- LSI Medience Corporation
- Start
- Sep 2022
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of somapacitan and somatrogon (2 arms), sponsored by LSI Medience Corporation. Primary endpoint: Evaluation of analytical method using detectable period of unchanged drug and metabolites. Started Sep 2022; status: completed.
02
Drugs
somapacitansomatrogon
Beyond the preview
Go deeper on jRCT1001220001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1001220001.